SCHEMBL5172935

SCHEMBL5172935

CCOc1ccc(NC(=O)[CH]Cc2ccc(C(=O)C(N)=O)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TP53 P04637 2/20 0.50
KMT2A Q03164 4/20 0.49
MEN1 O00255 2/20 0.49
CYP1A2 P05177 2/20 0.48
KDM4E B2RXH2 1/20 0.48
POLB P06746 3/20 0.48
LMNA P02545 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPT P10636 6/20 0.47
EGFR P00533 1/20 0.47
PARP10 Q53GL7 1/20 0.47
F2 P00734 1/20 0.45
F10 P00742 1/20 0.45
PLAU P00749 1/20 0.45
PLAT P00750 1/20 0.45
SAE1 Q9UBE0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL631095 0.81 ALDH1A1 (0.51) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL630245 0.79 RAB9A (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL30445926 0.73 KMT2A (0.69) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL27266001 0.72 ALDH1A1 (0.75) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL177957 0.71 ALDH1A1 (1.00) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL28617126 0.71 EGFR (0.66) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL8548307 0.70 TGM2 (0.68) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL11227015 0.70 KMT2A (0.65) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL27608220 0.70 ALDH1A1 (0.96) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL630339 0.70 MAPT (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP claimed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO claimed
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP disclosed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO disclosed